M

MoonLake Immunotherapeutics
D

MLTX

9.89500
USD
-0.24
(-2.32%)
مغلق
حجم التداول
110,748
الربح لكل سهم
-3
العائد الربحي
-
P/E
-4
حجم السوق
628,346,373
أصول ذات صلة الأخبار المقالات

العنوان: MoonLake Immunotherapeutics

القطاع: Healthcare
الصناعة: Biotechnology
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.